• Phone: +1-631-791-1145
  • Email: sales@imarcgroup.com

*As the coronavirus disease (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the purchase behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.

Hypoactive Sexual Desire Disorder Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025

Market Overview:

The global hypoactive sexual desire disorder treatment market grew at a CAGR of around 6% during 2014-2019. Hypoactive sexual desire disorder (HSDD) refers to a medical condition with low libido or sexual desire in women. The sexual dysfunction in HSDD is primarily associated with hyperfunction inhibition and hypofunctional excitation regulated by neuromodulators in the brain. Furthermore, several physical conditions are also related to HSDD, including anxiety, depression, diabetes, urinary incontinence, menopause, multiple sclerosis, etc. HSDD treatment mainly includes psychotherapy or pharmacotherapy. Psychotherapy utilizes cognitive behavioral therapy, which offers counseling sessions with a sex therapist, whereas pharmacotherapy comprises of treatment with several drugs, such as Buspirone, Bupropion, Testosterone, Flibanserin, etc.

The rising working women population coupled with their hectic work schedules often result in low libido conditions, thereby augmenting the demand for HSDD treatment. Furthermore, the high prevalence of numerous lifestyle ailments, such as anxiety, stress, depression, prolonged fatigue, irregular menstruation, etc., is also catalyzing the incidences of HSDD.  Additionally, diminished libido can also be a side-effect of certain chemical-based drugs that may further lead imbalance of neurotransmitters in the brain, causing HSDD. Moreover, the rising aging women population, premature menopause, and low self-esteem towards one’s physical appearance is also associated with low libido in women, thereby driving the demand for HSDD treatment. Besides this, the reducing stigma associated with HSDD coupled with the growing awareness towards the disease diagnosis and effective treatment is further propelling the market growth. The emergence of the PLISSIT model (Permission, Limited Information, Specific Suggestions, and Intensive Therapy) aids in the initial screening of HSDD. Furthermore, the faster drug approvals for treating HSDD along with the increasing investments in new drug development activities are further catalyzing the market growth. For instance, the U.S. Food and Drug Administration (FDA) approved ‘Vyleesi’ that activates melanocortin receptors for improving sexual desire in women. Looking forward, the IMARC Group expects the global hypoactive sexual desire disorder treatment market to continue its moderate growth during the next five years.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global hypoactive sexual desire disorder treatment market report, along with forecasts for growth at the global, regional and country level from 2020-2025. Our report has categorized the market based on region, therapy, distribution channel and application.

Breakup by Therapy:

  • Buspirone
  • Bupropion
  • Testosterone
  • Flibanserin
  • Bremelanotide
  • Cognitive Behavior Therapy 
     

Breakup by Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
     

Breakup by Application:

  • Hospitals
  • Clinics
  • Others
     

Breakup by Region:

  • North America
    • United States
    • Canada
  • Europe
    • United Kingdom
    • Germany
    • France
    • Spain
    • Italy
    • Russia
    • Others
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Others
  • Middle East and Africa
    • Saudi Arabia
    • Iran
    • Turkey
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
       

Competitive Landscape:

The competitive landscape of the industry has also been examined with some of the key players being Allergan Plc, AMAG Pharmaceuticals, Inc., Emotional Brain BV, Endoceutics, Inc., GlaxoSmithKline Plc, Ovoca Bio Plc, Pivot Pharmaceuticals, Inc., Palatin Technologies, Inc., S1 Biopharma, Inc., and Sprout Pharmaceuticals, Inc.

Key Questions Answered in This Report:

  • How has the global hypoactive sexual desire disorder treatment market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global hypoactive sexual desire disorder treatment market?
  • What are the key regional markets?
  • What is the breakup of the market based on the therapy?
  • What is the breakup of the market based on the distribution channel?
  • What is the breakup of the market based on the application?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global hypoactive sexual desire disorder treatment market and who are the key players?
  • What is the degree of competition in the industry?

1    Preface
2    Scope and Methodology 

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3    Executive Summary
4    Introduction

    4.1    Overview
    4.2    Key Industry Trends
5    Global Hypoactive Sexual Desire Disorder Treatment (HSDDT) Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6    Market Breakup by Therapy
    6.1    Buspirone
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    Bupropion
        6.2.1 Market Trends
        6.2.2 Market Forecast
    6.3    Testosterone
        6.3.1 Market Trends
        6.3.2 Market Forecast
    6.4    Flibanserin
        6.4.1 Market Trends
        6.4.2 Market Forecast
    6.5    Bremelanotide
        6.5.1 Market Trends
        6.5.2 Market Forecast
    6.6    Cognitive Behavior Therapy
        6.6.1 Market Trends
        6.6.2 Market Forecast
7    Market Breakup by Distribution Channel 
    7.1    Hospital Pharmacies
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Retail Pharmacies
        7.2.1 Market Trends
        7.2.2 Market Forecast
    7.3    Online Pharmacies
        7.3.1 Market Trends
        7.3.2 Market Forecast
8    Market Breakup by Application
    8.1    Hospitals
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    Clinics
        8.2.1 Market Trends
        8.2.2 Market Forecast
    8.3    Others
        8.3.1 Market Trends
        8.3.2 Market Forecast
9    Market Breakup by Region
    9.1    North America
        9.1.1 United States
           9.1.1.1 Market Trends
           9.1.1.2 Market Forecast
        9.1.2 Canada
           9.1.2.1 Market Trends
           9.1.2.2 Market Forecast
    9.2    Europe
        9.2.1 United Kingdom 
           9.2.1.1 Market Trends
           9.2.1.2 Market Forecast
        9.2.2 Germany 
           9.2.2.1 Market Trends
           9.2.2.2 Market Forecast
        9.2.3 France
           9.2.3.1 Market Trends
           9.2.3.2 Market Forecast
        9.2.4 Spain
           9.2.4.1 Market Trends
           9.2.4.2 Market Forecast
        9.2.5 Italy
           9.2.5.1 Market Trends
           9.2.5.2 Market Forecast
        9.2.6 Russia
           9.2.6.1 Market Trends
           9.2.6.2 Market Forecast
        9.2.7 Others
           9.2.7.1 Market Trends
           9.2.7.2 Market Forecast
    9.3    Asia Pacific
        9.3.1 China
           9.3.1.1 Market Trends
           9.3.1.2 Market Forecast
        9.3.2 Japan
           9.3.2.1 Market Trends
           9.3.2.2 Market Forecast
        9.3.3 India
           9.3.3.1 Market Trends
           9.3.3.2 Market Forecast
        9.3.4 South Korea
           9.3.4.1 Market Trends
           9.3.4.2 Market Forecast
        9.3.5 Others
           9.3.5.1 Market Trends
           9.3.5.2 Market Forecast
    9.4    Middle East and Africa
        9.4.1 Saudi Arabia
           9.4.1.1 Market Trends
           9.4.1.2 Market Forecast
        9.4.2 Iran
           9.4.2.1 Market Trends
           9.4.2.2 Market Forecast
        9.4.3 Turkey
           9.4.3.1 Market Trends
           9.4.3.2 Market Forecast
        9.4.4 Turkey
           9.4.4.1 Market Trends
           9.4.4.2 Market Forecast
    9.5    Latin America
        9.5.1 Brazil
           9.5.1.1 Market Trends
           9.5.1.2 Market Forecast
        9.5.2 Mexico
           9.5.2.1 Market Trends
           9.5.2.2 Market Forecast
        9.5.3 Others
           9.5.3.1 Market Trends
           9.5.3.2 Market Forecast
10    SWOT Analysis
    10.1    Overview
    10.2    Strengths
    10.3    Weaknesses
    10.4    Opportunities
    10.5    Threats
11    Value Chain Analysis
12    Porters Five Forces Analysis

    12.1    Overview
    12.2    Bargaining Power of Buyers
    12.3    Bargaining Power of Suppliers
    12.4    Degree of Competition
    12.5    Threat of New Entrants
    12.6    Threat of Substitutes
13    Competitive Landscape
    13.1    Market Structure
    13.2    Key Players
    13.3    Profiles of Key Players
        13.3.1    Allergan Plc
           13.3.1.1 Company Overview
           13.3.1.2 Product Portfolio 
        13.3.2    AMAG Pharmaceuticals, Inc.
           13.3.2.1 Company Overview
           13.3.2.2 Product Portfolio
           13.3.2.3 Financials
           13.3.2.4 SWOT Analysis
        13.3.3    Emotional Brain BV
           13.3.3.1 Company Overview
           13.3.3.2 Product Portfolio 
        13.3.4    Endoceutics, Inc.
           13.3.4.1 Company Overview
           13.3.4.2 Product Portfolio 
        13.3.5    GlaxoSmithKline Plc
           13.3.5.1 Company Overview
           13.3.5.2 Product Portfolio
           13.3.5.3 Financials
           13.3.5.4 SWOT Analysis
        13.3.6    Ovoca Bio Plc
           13.3.6.1 Company Overview
           13.3.6.2 Product Portfolio 
        13.3.7    Pivot Pharmaceuticals, Inc.
           13.3.7.1 Company Overview
           13.3.7.2 Product Portfolio
        13.3.8    Palatin Technologies, Inc. 
           13.3.8.1 Company Overview
           13.3.8.2 Product Portfolio 
           13.3.8.3 Financials
           13.3.8.4 SWOT Analysis
        13.3.9    S1 Biopharma, Inc 
           13.3.9.1 Company Overview
           13.3.9.2 Product Portfolio
           13.3.9.3 Financials
        13.3.10    Sprout Pharmaceuticals, Inc.
           13.3.10.1 Company Overview
           13.3.10.2 Product Portfolio 

List of Figures

Figure 1: Global: Hypoactive Sexual Desire Disorder Treatment Market: Major Drivers and Challenges 
Figure 2: Global: Hypoactive Sexual Desire Disorder Treatment Market: Sales Value (in Million US$), 2014-2019
Figure 3: Global: Hypoactive Sexual Desire Disorder Treatment Market: Breakup by Therapy (in %), 2019
Figure 4: Global: Hypoactive Sexual Desire Disorder Treatment Market: Breakup by Distribution Channel (in %), 2019
Figure 5: Global: Hypoactive Sexual Desire Disorder Treatment Market: Breakup by Application (in %), 2019
Figure 6: Global: Hypoactive Sexual Desire Disorder Treatment Market: Breakup by Region (in %), 2019
Figure 7: Global: Hypoactive Sexual Desire Disorder Treatment Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 8: Global: Hypoactive Sexual Desire Disorder Treatment (Buspirone) Market: Sales Value (in Million US$), 2014 & 2019
Figure 9: Global: Hypoactive Sexual Desire Disorder Treatment (Buspirone) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 10: Global: Hypoactive Sexual Desire Disorder Treatment (Bupropion) Market: Sales Value (in Million US$), 2014 & 2019
Figure 11: Global: Hypoactive Sexual Desire Disorder Treatment (Bupropion) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 12: Global: Hypoactive Sexual Desire Disorder Treatment (Testosterone) Market: Sales Value (in Million US$), 2014 & 2019
Figure 13: Global: Hypoactive Sexual Desire Disorder Treatment (Testosterone) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 14: Global: Hypoactive Sexual Desire Disorder Treatment (Flibanserin) Market: Sales Value (in Million US$), 2014 & 2019
Figure 15: Global: Hypoactive Sexual Desire Disorder Treatment (Flibanserin) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 16: Global: Hypoactive Sexual Desire Disorder Treatment (Bremelanotide) Market: Sales Value (in Million US$), 2014 & 2019
Figure 17: Global: Hypoactive Sexual Desire Disorder Treatment (Bremelanotide) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 18: Global: Hypoactive Sexual Desire Disorder Treatment (Cognitive Behaviour Therapy) Market: Sales Value (in Million US$), 2014 & 2019
Figure 19: Global: Hypoactive Sexual Desire Disorder Treatment (Cognitive Behaviour Therapy) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 20: Global: Hypoactive Sexual Desire Disorder Treatment (Hospital Pharmacies) Market: Sales Value (in Million US$), 2014 & 2019
Figure 21: Global: Hypoactive Sexual Desire Disorder Treatment (Hospital Pharmacies) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 22: Global: Hypoactive Sexual Desire Disorder Treatment (Retail Pharmacies) Market: Sales Value (in Million US$), 2014 & 2019
Figure 23: Global: Hypoactive Sexual Desire Disorder Treatment (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 24: Global: Hypoactive Sexual Desire Disorder Treatment (Online Pharmacies) Market: Sales Value (in Million US$), 2014 & 2019
Figure 25: Global: Hypoactive Sexual Desire Disorder Treatment (Online Pharmacies) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 26: Global: Hypoactive Sexual Desire Disorder Treatment (Hospitals) Market: Sales Value (in Million US$), 2014 & 2019
Figure 27: Global: Hypoactive Sexual Desire Disorder Treatment (Hospitals) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 28: Global: Hypoactive Sexual Desire Disorder Treatment (Clinics) Market: Sales Value (in Million US$), 2014 & 2019
Figure 29: Global: Hypoactive Sexual Desire Disorder Treatment (Clinics) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 30: Global: Hypoactive Sexual Desire Disorder Treatment (Other Applications) Market: Sales Value (in Million US$), 2014 & 2019
Figure 31: Global: Hypoactive Sexual Desire Disorder Treatment (Other Applications) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 32: North America: Hypoactive Sexual Desire Disorder Treatment Market: Sales Value (in Million US$), 2014 & 2019
Figure 33: North America: Hypoactive Sexual Desire Disorder Treatment Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 34: United States: Hypoactive Sexual Desire Disorder Treatment Market: Sales Value (in Million US$), 2014 & 2019
Figure 35: United States: Hypoactive Sexual Desire Disorder Treatment Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 36: Canada: Hypoactive Sexual Desire Disorder Treatment Market: Sales Value (in Million US$), 2014 & 2019
Figure 37: Canada: Hypoactive Sexual Desire Disorder Treatment Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 38: Europe: Hypoactive Sexual Desire Disorder Treatment Market: Sales Value (in Million US$), 2014 & 2019
Figure 39: Europe: Hypoactive Sexual Desire Disorder Treatment Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 40: United Kingdom: Hypoactive Sexual Desire Disorder Treatment Market: Sales Value (in Million US$), 2014 & 2019
Figure 41: United Kingdom: Hypoactive Sexual Desire Disorder Treatment Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 42: Germany: Hypoactive Sexual Desire Disorder Treatment Market: Sales Value (in Million US$), 2014 & 2019
Figure 43: Germany: Hypoactive Sexual Desire Disorder Treatment Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 44: France: Hypoactive Sexual Desire Disorder Treatment Market: Sales Value (in Million US$), 2014 & 2019
Figure 45: France: Hypoactive Sexual Desire Disorder Treatment Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 46: Spain: Hypoactive Sexual Desire Disorder Treatment Market: Sales Value (in Million US$), 2014 & 2019
Figure 47: Spain: Hypoactive Sexual Desire Disorder Treatment Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 48: Italy: Hypoactive Sexual Desire Disorder Treatment Market: Sales Value (in Million US$), 2014 & 2019
Figure 49: Italy: Hypoactive Sexual Desire Disorder Treatment Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 50: Russia: Hypoactive Sexual Desire Disorder Treatment Market: Sales Value (in Million US$), 2014 & 2019
Figure 51: Russia: Hypoactive Sexual Desire Disorder Treatment Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 52: Others: Hypoactive Sexual Desire Disorder Treatment Market: Sales Value (in Million US$), 2014 & 2019
Figure 53: Others: Hypoactive Sexual Desire Disorder Treatment Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 54: Asia Pacific: Hypoactive Sexual Desire Disorder Treatment Market: Sales Value (in Million US$), 2014 & 2019
Figure 55: Asia Pacific: Hypoactive Sexual Desire Disorder Treatment Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 56: China: Hypoactive Sexual Desire Disorder Treatment Market: Sales Value (in Million US$), 2014 & 2019
Figure 57: China: Hypoactive Sexual Desire Disorder Treatment Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 58: Japan: Hypoactive Sexual Desire Disorder Treatment Market: Sales Value (in Million US$), 2014 & 2019
Figure 59: Japan: Hypoactive Sexual Desire Disorder Treatment Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 60: India: Hypoactive Sexual Desire Disorder Treatment Market: Sales Value (in Million US$), 2014 & 2019
Figure 61: India: Hypoactive Sexual Desire Disorder Treatment Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 62: South Korea: Hypoactive Sexual Desire Disorder Treatment Market: Sales Value (in Million US$), 2014 & 2019
Figure 63: South Korea: Hypoactive Sexual Desire Disorder Treatment Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 64: Others: Hypoactive Sexual Desire Disorder Treatment Market: Sales Value (in Million US$), 2014 & 2019
Figure 65: Others: Hypoactive Sexual Desire Disorder Treatment Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 66: Middle East and Africa: Hypoactive Sexual Desire Disorder Treatment Market: Sales Value (in Million US$), 2014 & 2019
Figure 67: Middle East and Africa: Hypoactive Sexual Desire Disorder Treatment Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 68: Saudi Arabia: Hypoactive Sexual Desire Disorder Treatment Market: Sales Value (in Million US$), 2014 & 2019
Figure 69: Saudi Arabia: Hypoactive Sexual Desire Disorder Treatment Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 70: Iran: Hypoactive Sexual Desire Disorder Treatment Market: Sales Value (in Million US$), 2014 & 2019
Figure 71: Iran: Hypoactive Sexual Desire Disorder Treatment Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 72: Turkey: Hypoactive Sexual Desire Disorder Treatment Market: Sales Value (in Million US$), 2014 & 2019
Figure 73: Turkey: Hypoactive Sexual Desire Disorder Treatment Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 74: Others: Hypoactive Sexual Desire Disorder Treatment Market: Sales Value (in Million US$), 2014 & 2019
Figure 75: Others: Hypoactive Sexual Desire Disorder Treatment Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 76: Latin America: Hypoactive Sexual Desire Disorder Treatment Market: Sales Value (in Million US$), 2014 & 2019
Figure 77: Latin America: Hypoactive Sexual Desire Disorder Treatment Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 78: Brazil: Hypoactive Sexual Desire Disorder Treatment Market: Sales Value (in Million US$), 2014 & 2019
Figure 79: Brazil: Hypoactive Sexual Desire Disorder Treatment Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 80: Mexico: Hypoactive Sexual Desire Disorder Treatment Market: Sales Value (in Million US$), 2014 & 2019
Figure 81: Mexico: Hypoactive Sexual Desire Disorder Treatment Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 82: Others: Hypoactive Sexual Desire Disorder Treatment Market: Sales Value (in Million US$), 2014 & 2019
Figure 83: Others: Hypoactive Sexual Desire Disorder Treatment Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 84: Global: Hypoactive Sexual Desire Disorder Treatment Industry: SWOT Analysis
Figure 85: Global: Hypoactive Sexual Desire Disorder Treatment Industry: Value Chain Analysis
Figure 86: Global: Hypoactive Sexual Desire Disorder Treatment Industry: Porter’s Five Forces Analysis

List of Tables

Table 1: Global: Hypoactive Sexual Desire Disorder Treatment Market: Key Industry Highlights, 2019 and 2025
Table 2: Global: Hypoactive Sexual Desire Disorder Treatment Market Forecast: Breakup by Therapy (in Million US$), 2020-2025
Table 3: Global: Hypoactive Sexual Desire Disorder Treatment Market Forecast: Breakup by Distribution Channel (in Million US$), 2020-2025
Table 4: Global: Hypoactive Sexual Desire Disorder Treatment Market Forecast: Breakup by Application (in Million US$), 2020-2025
Table 5: Global: Hypoactive Sexual Desire Disorder Treatment Market Forecast: Breakup by Region (in Million US$), 2020-2025
Table 6: Global: Hypoactive Sexual Desire Disorder Treatment Market: Competitive Structure
Table 7: Global: Hypoactive Sexual Desire Disorder Treatment Market: Key Players

Note: We value your privacy and will never rent or sell your email address. Privacy policy

Purchase Options




$ 2299

REACH OUT TO US

Call us on

( US: +1-631-791-1145 )
( UK: +44-702-409-7331 )
( India: +91-120-433-0800 )


Drop us an email at

sales@imarcgroup.com

Social Links